227.68
price up icon1.72%   3.85
 
loading

왜 Becton Dickinson Co (BDX) 주가가 하락하고 있습니까?

2024-11-07 거래 세션 동안 Becton Dickinson Co(BDX) 주식이 5.39% 하락한 것을 확인했습니다. 이는 정상적인 변동성이나 다양한 내부 및 외부 요인에 의한 것일 수 있지만, 상황을 적극적으로 모니터링하고 있으며 최대한 빨리 적시에 업데이트를 제공하도록 하겠습니다!
2023-11-09:

Shares of Becton Dickinson And Company (BDX) dropped by 9.25% from $255.92 to $232.24 in the trading on Thursday, Novemeber 9, 2023. The reasons why BDX down include:

  • Mixed Q4 Earnings: BD reported adjusted earnings per share (EPS) of $3.42 for Q4 2023, marking a 24.4% year-over-year increase. However, this figure was in line with analyst expectations, leading to mixed sentiment. The full-year adjusted EPS of $12.21 represented a 7.6% increase compared to the previous fiscal year but slightly missed the consensus estimate. BD's Q4 2023 revenues were $5.09 billion, surpassing expectations and showing a 6.8% year-over-year growth. Full-year revenues also exceeded estimates. BD's various business segments, including BD Medical, BD Life Sciences, and BD Interventional, reported revenue performances in line with or slightly below analysts' estimates.
  • Concerns about margin contraction: BD's gross profit decreased by 18.1% in Q4, with a significant gross margin contraction of 1017 basis points. Operating profit and margin also saw declines.
  • Disappointing FY2024 Guidance: BD provided its fiscal 2024 outlook, with projected revenues, organic revenue growth, and adjusted EPS falling within the range of analyst expectations.
medical_instruments_supplies ALC
$84.76
price up icon 0.69%
medical_instruments_supplies RMD
$237.27
price up icon 2.46%
medical_instruments_supplies WST
$331.40
price up icon 1.34%
medical_instruments_supplies COO
$93.44
price up icon 1.64%
$71.65
price up icon 1.26%
자본화:     |  볼륨(24시간):